Study details
Enrolling now
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
University of Alabama at Birmingham
NCT IDNCT06989320ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 6.6 years
Ages
18–80
Locations
2 sites in AL, TX
About this study
This trial is testing if people with kidney stones have increased oxalate production. Participants will follow a low-oxalate diet and take supplements to measure how much oxalate their body makes.
Based on ClinicalTrials.gov records.
What participants do
- 1.Low-oxalate diet and glycolate dosing
- 2.Oral 13C- ascorbic acid dosing
- 3.Oral glycolate dosing
DrugOral 13C- ascorbic acid dosing
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ALIMENTARY TRACT AND METABOLISM
Drug routes
oral (Oral Capsule), topical (Topical Gel)
Body systems
Renal